active
Ceramides
If 2026's defining formulation story is barrier biology, ceramides are its load-bearing wall — ~50% of the stratum corneum's lipid architecture. The 2026 priority is replicating the skin's complete lipid system (ceramide + cholesterol + fatty acids in physiological ratios), not just adding a single ceramide. In-Cosmetics 2026 highlighted ceramide-producing microbes as a biotech frontier.
Benefits
- restores barrier lipid architecture
- reduces transepidermal water loss
- calms eczema- and rosacea-prone skin
Example uses
- barrier creams
- moisturizers for compromised skin
- post-acid recovery
Mechanism of action
Sphingoid-base lipids that comprise ~50% of stratum corneum intercellular lipid mass — covalently bound to corneocyte envelopes and stacked with cholesterol and free fatty acids into multilamellar bilayers that constitute the primary water-permeability barrier. Topical replacement integrates into damaged bilayers when delivered in physiological multi-lipid ratios (3:1:1 ceramide:cholesterol:fatty acid for repair-skewed; 1:1:1 for maintenance). Single-ceramide products without cholesterol and free fatty acids have been shown to potentially delay rather than accelerate barrier recovery — the famous Man-Elias finding that drives the multilamellar formulation standard.
Clinical evidence · High
Decades of dermatology evidence for barrier dysfunction (atopic dermatitis, eczema, post-laser), notably the CeraVe / EpiCeramide MD literature; less robust for everyday cosmetic anti-aging endpoints.
Effective concentration range
0.1–1% total ceramide (in physiological lipid mix)
Formulation notes
Best formulated as multilamellar / 'skin-identical' systems — ceramide + cholesterol + fatty acids in 1:1:1 or 3:1:1 ratios.
Watchouts
Conventional ceramides were once bovine-brain-derived; insist on plant or biofermentation sourcing for clean positioning.
Controversies & overclaims
The historical sourcing controversy (bovine-brain ceramide) is essentially closed — modern cosmetic ceramides are plant- or biofermentation-derived. The active controversy is formulation honesty: many 'ceramide' products use a token amount of one ceramide without cholesterol and free fatty acids, missing the physiological ratio that defines actual barrier repair. The numbered nomenclature (NP, AP, EOS) is not consumer-readable.
Market positioning
Sold as the molecule that 'rebuilds the skin barrier' — broadly accurate when formulated multilamellarly, broadly aspirational otherwise. The CeraVe and Dr. Jart V7 lines anchor the category; many followers are ceramide-as-decoration.
Comedogenicity
0 / 5
Sensitisation risk
Low
INCI & aliases
Ceramide NP / NS / AP / EOP / EOS (numbered series)
Clean beauty perception
Strongly positive — infrastructure ingredient, not a trend.
Products using Ceramides
Related ingredients
Graph relationships
Timeline